|
|
Founded in 2005, Baiyu Group is located in Chengdu-the hometown of pandas, in Sichuan Province, P. R. China. It is a group co***ny with about 1000 staff engaged in medicinal plant agriculture, research and development, manufacturing and global distribution.
Baiyu Group is rapidly developing and has been awarded ¡°National High-tech Enterprise¡±, ¡°Sichuan Famous Brand¡± and ¡°Enterprises with the most investment value in Chinese pharmaceutical industry¡± in 3 consecutive years.
Baiyu has rich product pipelines, with particular focus on cardio-cerebrovascular and neurological areas. Ginkgolide Injection, the world¡¯s exclusive ginkgo product with high purity of ginkgolide and bilobalide, has won many awards, obtained more than 10 global patents and is widely used to treat ischemic and other cardio-cerebrovascular diseases.
Based on QbD concept, Baiyu strictly complies with US/EU GMP requirements, has passed Chinese GMP inspection and is expected to pass EU GMP inspection by H2, 2018.
Actually Baiyu is extending its global business in a fast pace. We welcome partners to work with us to register/distribute our products in your region and to cooperate in flexible ways that may bring us mutual benefit.
|
| Company: |
Chengdu Baiyu Pharmaceutical Co.,Ltd
|
| Contact: |
Ms. Lily He |
| Address: |
No.343, HeZuo Road, West Hi-Tech Zone |
| Postcode: |
611730 |
| Tel: |
+86 028-83379750 |
| Fax: |
+86-28-61683990-8004 |
| E-mail: |
|
|
|
|
Home
